Happy August. We take a deep dive into the emotional testimonies at last week’s FTC hearing on the impact of PBMs, and why it’s more important than ever to get your seasonal flu shot. Get the details below, plus more news you need to know this week. (670 words, 3 minutes, 21 seconds)
We’re back with a recap of yesterday’s House Oversight hearing with the three largest PBMs, what BIO’s saying about the Farm Bill, and more. (730 words, 3 minutes, 39 seconds)
At long last, the FTC released an interim report on PBMs—and the findings are not surprising. We have details, plus more about the winners of BIO’s 2024 Agri-Biotechnology Awards. Don’t forget to take our reader survey! (523 words, 2 minutes, 36 seconds)
A busy Thursday on Capitol Hill brought lots of talk about PBMs—we have a recap, plus a look at why we need to invest more in women’s health and R&D. (509 words, 3 minutes, 32 seconds)
It’s an exciting week, as we officially welcome John Crowley as BIO’s CEO. Meanwhile, we look at what happened at the WTO last week, and what’s ahead at the White House listening session on PBMs today. (623 words, 3 minutes, 6 seconds)
A busy day on Capitol Hill advances legislation on PBMs and preventive care, and brings important discussions on antimicrobial resistance. Meanwhile, BIO tells the Biden administration why Bayh-Dole cannot be used for drug price controls. (587 words, 2 minutes, 56 seconds)
The good news: The House passed PBM reform legislation yesterday. The bad news: FTC M&A overreach is causing “lasting damage” to American life sciences innovation, experts write, with another blow for patients this week. (693 words, 3 minutes, 27 seconds)
Ending the week with a recap of recent PBM activity on the Hill—and how you can take action—and how biotech can help solve the growing plastic crisis. (548 words, 2 minutes, 44 seconds)
Shutdown averted—and the House Energy & Commerce Health Subcommittee advanced key legislation to rein in PBMs. Plus, two important climate reports this week highlight the need for government policy to advance existing biotech solutions. (542 words, 2 minutes, 42 seconds)
The Senate Finance Committee advanced critically important PBM transparency legislation—here’s what happened and how you can take action. Plus, BIO joined 45+ organizations in condemning the Biden administration’s recent decision on international data flows. (703 words, 3 minutes, 30 seconds)